FI822348L - Vid klamydiadiagnostik anvaendbart preparat - Google Patents

Vid klamydiadiagnostik anvaendbart preparat

Info

Publication number
FI822348L
FI822348L FI822348A FI822348A FI822348L FI 822348 L FI822348 L FI 822348L FI 822348 A FI822348 A FI 822348A FI 822348 A FI822348 A FI 822348A FI 822348 L FI822348 L FI 822348L
Authority
FI
Finland
Prior art keywords
chlamydial
preparations
klamydiadiagnostik
anvaendbart
preparat
Prior art date
Application number
FI822348A
Other languages
English (en)
Other versions
FI822348A0 (fi
FI69639B (fi
FI69639C (fi
Inventor
Pirjo Maekelae
Marjatta Nurminen-Kalliokoski
Maija Leinonen
Pekka Saikku
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of FI822348A0 publication Critical patent/FI822348A0/fi
Priority to FI822348A priority Critical patent/FI69639C/fi
Priority to US06/507,788 priority patent/US4652518A/en
Priority to EP83106453A priority patent/EP0098557B1/en
Priority to JP58118413A priority patent/JPS5927261A/ja
Priority to DK304483A priority patent/DK304483A/da
Priority to NO832407A priority patent/NO832407L/no
Priority to DE8383106453T priority patent/DE3372018D1/de
Priority to AT83106453T priority patent/ATE27739T1/de
Priority to DE198383106453T priority patent/DE98557T1/de
Priority to AU16492/83A priority patent/AU1649283A/en
Priority to CA000431720A priority patent/CA1230551A/en
Publication of FI822348L publication Critical patent/FI822348L/fi
Publication of FI69639B publication Critical patent/FI69639B/fi
Application granted granted Critical
Publication of FI69639C publication Critical patent/FI69639C/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/295—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/879—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI822348A 1982-07-02 1982-07-02 Preparat foer anvaendning vid klamydia-diagnostik FI69639C (fi)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FI822348A FI69639C (fi) 1982-07-02 1982-07-02 Preparat foer anvaendning vid klamydia-diagnostik
US06/507,788 US4652518A (en) 1982-07-02 1983-06-24 Diagnosing chlamydia infections with Re-lipopolysaccharide complexed to carrier or antibody thereto
DE8383106453T DE3372018D1 (en) 1982-07-02 1983-07-01 Preparation for the diagnosis of chlamydial infections and for the production of chlamydial group-specific antibodies
JP58118413A JPS5927261A (ja) 1982-07-02 1983-07-01 クラミジア感染症診断用製剤及びその使用方法
DK304483A DK304483A (da) 1982-07-02 1983-07-01 Praeparat til anvendelse ved diagnose af infektioner med chlamydia
NO832407A NO832407L (no) 1982-07-02 1983-07-01 Preparat for anvendelse ved diagnose av chlamydiale infeksjoner.
EP83106453A EP0098557B1 (en) 1982-07-02 1983-07-01 Preparation for the diagnosis of chlamydial infections and for the production of chlamydial group-specific antibodies
AT83106453T ATE27739T1 (de) 1982-07-02 1983-07-01 Praeparat zur diagnose von chlamydia-infektionen und zur gewinnung der chlamydiagruppespezifischen antikoerper.
DE198383106453T DE98557T1 (de) 1982-07-02 1983-07-01 Praeparat zur diagnose von chlamydia-infektionen und zur gewinnung der chlamydiagruppe-spezifischen antikoerper.
AU16492/83A AU1649283A (en) 1982-07-02 1983-07-01 Diagnosis of chlamydial infections
CA000431720A CA1230551A (en) 1982-07-02 1983-07-04 Preparation to be used in diagnosis of chlamydial infections

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI822348A FI69639C (fi) 1982-07-02 1982-07-02 Preparat foer anvaendning vid klamydia-diagnostik
FI822348 1982-07-02

Publications (4)

Publication Number Publication Date
FI822348A0 FI822348A0 (fi) 1982-07-02
FI822348L true FI822348L (fi) 1984-01-03
FI69639B FI69639B (fi) 1985-11-29
FI69639C FI69639C (fi) 1986-03-10

Family

ID=8515769

Family Applications (1)

Application Number Title Priority Date Filing Date
FI822348A FI69639C (fi) 1982-07-02 1982-07-02 Preparat foer anvaendning vid klamydia-diagnostik

Country Status (10)

Country Link
US (1) US4652518A (fi)
EP (1) EP0098557B1 (fi)
JP (1) JPS5927261A (fi)
AT (1) ATE27739T1 (fi)
AU (1) AU1649283A (fi)
CA (1) CA1230551A (fi)
DE (2) DE98557T1 (fi)
DK (1) DK304483A (fi)
FI (1) FI69639C (fi)
NO (1) NO832407L (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818817A (en) * 1983-11-30 1989-04-04 Petroleum Fermentations N.V. Enzymatic degradation of lipopolysaccharide bioemulsifiers
CA1212051A (en) * 1984-03-02 1986-09-30 John W. Cherwonogrodzky Identification of brucella abortus and brucellosis infection
GB8416841D0 (en) * 1984-07-03 1984-08-08 Technology Licence Co Ltd Monoclonal antibodies
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
GB8427006D0 (en) * 1984-10-25 1984-11-28 Iq Bio Ltd Determination of chlamydia trachomatis
US5179001A (en) * 1985-09-27 1993-01-12 The Regents Of The University Of California Detection and monitoring of chronic and gram-negative infection
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
ES2009365A6 (es) * 1986-04-24 1989-09-16 Univ California Procedimiento de otencion de anticuerpos monoclonales para bacterias gram-negativas.
CA1336576C (en) * 1986-09-26 1995-08-08 Malcolm B. Perry Immunoassays for discriminating between brucellosis infections and vaccinations
EP0303515B1 (en) * 1987-08-13 1992-11-11 Synbiotics Corporation Improved amphipathic analyte assays using lipophilic surface
US4916057A (en) * 1988-02-29 1990-04-10 Kallestad Diagnostics, Inc. Chlamydia assay employing base treatment
FR2631125A1 (fr) * 1988-05-06 1989-11-10 Pasteur Institut Procede de detection directe de chlamydiae, anticorps monoclonaux anti-chlamydiae et leurs applications au diagnostic des infections chlamydiales
US5089479A (en) * 1988-11-28 1992-02-18 Krivan Howard C Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide
US5484706A (en) * 1993-05-19 1996-01-16 Pasteur Sanofi Diagnostics Immunoassay for analytes in samples using alkylating agents
AU660268B3 (en) * 1993-07-16 1995-06-15 Deakin University Bacteria-specific lipopolysaccharide-like molecules
US5773234A (en) * 1995-08-07 1998-06-30 Quidel Corporation Method and device for chlamydia detection
JPH10339731A (ja) * 1997-06-06 1998-12-22 Mitsubishi Chem Corp 腸管出血性大腸菌感染の検出方法
US7220596B2 (en) * 1998-04-15 2007-05-22 Utah State University Real time detection of antigens
US6399317B1 (en) 1998-04-15 2002-06-04 Utah State University Real time detection of antigens
CA2664619C (en) * 2006-10-12 2012-12-11 Glaxosmithkline Biologicals S.A. Immunogenic compositions comprising an oil-in-water emulsion adjuvant containing a reduced amount of squalene, tocol and an emulsifying agent
TW200908994A (en) 2007-04-20 2009-03-01 Glaxosmithkline Biolog Sa Vaccine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039657A (en) * 1975-06-19 1977-08-02 Merck & Co., Inc. Separating antigen from residual common sensitizing protein
US4118469A (en) * 1976-04-27 1978-10-03 Research Corporation Antigen for trachoma lymphogranuloma venereum (LGV) and non-gonococcal urethritis (NGU)
US4096035A (en) * 1977-06-15 1978-06-20 Merck & Co., Inc. Separation of trachoma agent from growth medium impurities
GB2047889A (en) * 1979-04-02 1980-12-03 Research Corp Detection of antibodies to chlormydia trachomatis having an immunofluorescence test
EP0017460A1 (en) * 1979-04-02 1980-10-15 Research Corporation Immunofluorescent test method and substance for use therein
US4310455A (en) * 1979-04-17 1982-01-12 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4271146A (en) * 1979-09-06 1981-06-02 Seawell Albert C Methods of using Chlamydia vaccine for preventing and treating bovine and ovine diseases
US4267170A (en) * 1979-09-06 1981-05-12 Seawell Albert C Methods of using chlamydia vaccine for preventing and treating bovine diseases
BR8108820A (pt) * 1980-09-24 1982-08-24 Cetus Corp Processo e sonda de diagnostico
US4397959A (en) * 1980-11-05 1983-08-09 Research Corporation Forced precipitation method for preparing antigen/antibody particles
US4497899A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Chlamydia trachomatis antigens

Also Published As

Publication number Publication date
NO832407L (no) 1984-01-03
DK304483A (da) 1984-01-03
FI822348A0 (fi) 1982-07-02
DE3372018D1 (en) 1987-07-16
US4652518A (en) 1987-03-24
FI69639B (fi) 1985-11-29
EP0098557B1 (en) 1987-06-10
JPS5927261A (ja) 1984-02-13
JPH0450531B2 (fi) 1992-08-14
DK304483D0 (da) 1983-07-01
DE98557T1 (de) 1984-07-05
EP0098557A3 (en) 1984-04-04
CA1230551A (en) 1987-12-22
ATE27739T1 (de) 1987-06-15
FI69639C (fi) 1986-03-10
AU1649283A (en) 1984-01-05
EP0098557A2 (en) 1984-01-18

Similar Documents

Publication Publication Date Title
FI822348A0 (fi) Vid klamydiadiagnostik anvaendbart preparat
SE8403871L (sv) Kemisk forening, anvendbar som mellanprodukt vid framstellning av vissa cyanoguanidinderivat
ATE167061T1 (de) Kreuzschützende salmonella impfstoffe
Halter et al. Lipooligosaccharides from Treponema hyodysenteriae and Treponema innocens
Rönnberg et al. Rapid detection by a coagglutination test of heat-labile enterotoxin in cell lysates from blood agar-grown Escherichia coli
ATE24018T1 (de) Polysaccharid-antigen aus streptococcus und impfstoffe.
Tamura et al. Edwardsiella tarda serotyping scheme for international use
De Almeida et al. Egg Yolk Anti‐BfpA Antibodies as a Tool for Recognizing and Identifying Enteropathogenic Escherichia coli
Young et al. “Core” glycolipid of Enterobacteriaceae: immunofluorescent detection of antigen and antibody
SE8104771L (sv) Cefalosporinderivat
Holmberg et al. Determination of antibodies to pneumococcal C polysaccharide in patients with community-acquired pneumonia
Dunn et al. Monoclonal antibodies protect against lethal effects of gram-negative bacterial sepsis.
Dowdle et al. A phage-fluorescent antiphage staining system for Bacillus anthracis
FI872719A (fi) Nya tetrahydro-benzotiazoler, deras framstaellning och anvaendning.
DiPierro et al. Enzymatic reversibility of flagellar immobilization
Xu et al. Preliminary extraction and identification of the 44.5 kDa outer membrane proteins isolated from bovine Fusobacterium necrophorum (AB)
BR8201893A (pt) Poli-bis-triazenilimidas processo para sua preparacao sua aplicacao processo para estabilizar polimeros sinteticos e polimeros assim estabilizados
Maeland et al. Human serum antibodies against heat‐stable antigens from Yersinia enterocolitica
Pestana de Castro et al. Haemagglutinating properties of Pasteurella multocida type A strains isolated from rabbits and poultry.
Saphra et al. Serological relationship amongst Salmonella and other Enterobacteriaceae
DK592988A (da) Laegemiddel, deri indeholdende phosphorholdige 2-isoxazoliner og isoxazoler, samt fremstilling af disse heterocycliske forbindelser
Tompkins Corynebacterium hemolyticum
Dowdle et al. Labeling of antibodies with fluorescent azo dyes
SE8703453D0 (sv) Preparation innehallande hogmolekylert bakteriellt protein, antikroppspreparation riktad deremot samt preparationernas anvendning
Block Antigenic polymorphism of the lamB protein among members of the family Enterobacteriaceae.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ORION-YHTYMAE OY